Here's Why COVID-Themed ETFs May Come Back Under the Radar
COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.'
Pharma & Biotech ETFs at One-Month High: Here's Why
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.